What question did this study set out to answer?

To report and discuss cases of cerebral demyelinating disease and encephalopathy following adjuvant therapy with levamisole alone.

January 1, 1996Neurology

Encephalopathies after levamisole therapy

View Full Paper

Ask AI

Bookmark

Authors

CCClaude ChastelInstitut de Virologie DMDominique MabinInserm

Discussion

Member takes

Implication

Case report reports cerebral demyelinating encephalopathy in a melanoma patient receiving levamisole, highlighting central nervous system toxicity from monotherapy.

Key Points

To report and discuss cases of cerebral demyelinating disease and encephalopathy following adjuvant therapy with levamisole alone.
Clinical evaluation of a 57-year-old female who developed demyelinating central nervous system pathology following a 5-week course of adjuvant levamisole for cutaneous malignant melanoma.
Comparison with historical cases of inflammatory multifocal leukoencephalopathy associated with combined levamisole and fluorouracil regimens.
Development of inflammatory cerebral demyelinating disease occurred after 5 weeks of levamisole monotherapy.
The clinical and neurological features closely mirrored inflammatory multifocal leukoencephalopathy previously documented only with combination levamisole and fluorouracil therapy.

Cite This Study

Chastel et al. (1996) studied this question.

synapsesocial.com/papers/6aaa3fff32645dcf6432a1b0 https://doi.org/10.1212/wnl.46.1.288

View Full Paper

Ask AI

Bookmark

Implication

Case report reports cerebral demyelinating encephalopathy in a melanoma patient receiving levamisole, highlighting central nervous system toxicity from monotherapy.

Encephalopathies after levamisole therapy

Discussion

Member takes

Implication

Key Points

Cite This Study

Encephalopathies after levamisole therapy

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider